Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment
Study Details
Study Description
Brief Summary
IVF is a well-established method to treat various causes of infertility. Some studies have suggested that ethnicity affects the success of IVF. This is a prospective study involving two tertiary IVF units in Hong Kong and Australia. The IVF outcome between Chinese and Caucasians will be compared.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
This is a prospective study conducted in two tertiary IVF units in Hong Kong and Australia.
The target population for the trial will be women undergoing IVF or intracytoplasmic sperm injection (ICSI) treatment in two IVF Units.
Intervention:
Patients recruited in this study will undergo IVF+/-ICSI treatment. They will undergo an ultrasound scan on the second or third day (day 2 or 3) of a period to exclude the presence of ovarian cyst and have the antral follicle count determined, which includes all follicles of 2-10 mm measured with a 5.5-7.5mHz transvaginal ultrasound probe. Blood will be checked for anti-mullerian hormone (AMH) measured by Beckman-Coulter Diagnostics.
Ovarian stimulation will be started if there are no ovarian cysts on ultrasound scan. They will receive one long acting gonadotrophin injection Elonva 150 microgram subcutaneously followed by daily gonadotrophin injections (Puregon) 200 IU in an antagonist protocol. Antagonist (orgalutran 0.25 mg) will be started on day 5 of ovarian stimulation. Transvaginal ultrasound will be performed for follicular tracking 7 days after the Elonva injection and every 1-3 days thereafter. No adjustment in FSH dose is allowed. Cycles will be cancelled if there are less than 3 follicles larger than 18mm after one week of 200 IU Puregon or there no developing follicle (i.e. larger than 11mm) after one week of 200 IU Puregon.
Recombinant hCG (Ovidrel, Serono, Bari, Italy) 0.25mg will be given if there are 2 follicles
18 mm in diameter. Gonadotrophin injection will not be given on the day of hCG. Agonist trigger will be used if oestradiol concentration on the day of trigger is greater than 15,000 pmol/L or there are more than 15 follicles >16mm on transvaginal scanning. All embryos or blastocysts will be frozen for transfer later following agonist trigger or when the number of oocytes aspirated is 20 or more. Serum FSH, oestradiol, LH and progesterone concentrations are taken 7 days after the Elonva injection and hCG trigger day. Transvaginal ultrasound-guided oocyte retrieval (TUGOR) will be scheduled on Mondays, Wednesdays and Fridays, 34-36 hours after the hCG injection. Flushing of follicles will not be performed. Follicular fluid not contaminated with blood will be collected from the first and largest follicle on each side for estradiol and progesterone level.
The retrieved oocyte will be inseminated conventionally or by ICSI, depending on the semen parameters. ICSI is advised if the total motile sperm number after sperm preparation < 0.2 million, sperm morphology by strict criteria < 3% or fertilization rate < 30% in previous IVF cycles with conventional insemination. One to two embryos will be replaced on day 2-5 after oocyte retrieval. Luteal phase support will be started according to the standard protocol of the centre. Patients will be followed up for urinary pregnancy test 16 days after embryo transfer. Patients with a positive pregnancy test will have transvaginal ultrasound scan performed 10-14 days later and are referred for antenatal care at 8-10 weeks gestation. The remaining embryos will be frozen. Pregnancy outcome will be monitored.
Study Design
Outcome Measures
Primary Outcome Measures
- Number of oocytes obtained [17 days]
Number of oocytes obtained
Secondary Outcome Measures
- Number of follicles smaller than 14, 16mm and larger than 18mm in diameter on day 8 and day of hCG [8 and day of hCG]
Number of follicles smaller than 14, 16mm and larger than 18mm in diameter on day 8 and day of hCG
- Duration of recombinant FSH [15 days]
Duration of recombinant FSH
- Dosage of recombinant FSH [15 days]
Dosage of recombinant FSH
- Serum estradiol levels on day 9 and day of hCG [9 and day of hCG]
Serum estradiol levels on day 9 and day of hCG
- Serum FSH levels on day 9 and day of hCG [9 and day of hCG]
Serum FSH levels on day 9 and day of hCG
- Serum LH levels on day 9 and day of hCG [9 and day of hCG]
Serum LH levels on day 9 and day of hCG
- Serum progesterone levels on day 9 and day of hCG [9 and day of hCG]
Serum progesterone levels on day 9 and day of hCG
- Miscarriage rate [24 weeks]
Miscarriage rate
- Clinical pregnancy rate [6 weeks]
Clinical pregnancy rate: presence of intrauterine gestational sac at 6 weeks
- Ongoing pregnancy rate [12 weeks]
Ongoing pregnancy rate: presence of fetal heart pulsation on transvaginal scan at 12 weeks
- Live birth rate [44 weeks]
Live birth rate
- Ovarian hyperstimulation rate [8 weeks]
Ovarian hyperstimulation rate (according to RCOG guideline)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Women age 18-36 years old
-
Body weight >60Kg
-
Total antral follicle count >=7 and ≤ 20 i.e. not poor ovarian reserve based on Bologna criteria
-
Chinese women in the HK centre and Caucasian women (defined as originating from the United Kingdom, Europe or United States of America, excluding the Middle East) in the Australian centre
-
Written informed consent
Exclusion Criteria:
-
Mixed race/ ethnicity
-
History of ovarian surgery
-
Body mass index >35 kg/m2
-
2 previous stimulated IVF cycles
-
History of ovarian hyperstimulation syndrome in previous stimulated IVF cycles
-
Polycystic ovary syndrome or total antral follicle count >20
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Department of Obstetrics and Gynaecology | Hong Kong | Hong Kong | China |
Sponsors and Collaborators
- The University of Hong Kong
- The University of New South Wales
Investigators
- Principal Investigator: Ernest HY Ng, Department of Obstetrics and Gynaecology, 6/F, Professorial Block, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- UW 15-547